“For Bormioli Pharma, this transaction is part of a wider strategy aimed at the divestiture of the non-strategic glass tubing business, currently operated in the San Vito plant, in order to focus on its core activities of developing and manufacturing innovative plastic and molded glass packaging solutions serving pharmaceutical customers' needs. This initiative represents a building block to be even more capable and proactive in partnering with customers in the evolution of the pharmaceutical industry and to become a global reference point for new frontiers in the field of health.” said Andrea Lodetti, CEO of Bormioli Pharma.

"All rights reserved except agreement written by Emballage Digest or mention of the magazine''